General Information |
|
Product |
MAP3K4 Antibody BIOTIN-Conjugated |
Description |
BIOTIN-Conjugated Mitogen-activated protein kinase kinase kinase 4 Antibody |
Verified Applications |
ELISA, IHC, IP, WB |
Host |
Rabbit |
Species Cross Reactivity |
Human, Mouse, Rat |
Immunogen |
Synthetic peptide taken within amino acid region 1558-1608 on human MAP3K4 protein. |
|
|
Quantity |
100 µg |
Volume |
200 µl |
Concentration |
0.50 µg/µl in antibody stabilization buffer |
Immunoglobulin |
IgG |
Form |
BIOTIN-Conjugated |
Clonality |
Polyclonal |
Storage |
-20⁰C for long term storage |
|
|
ELISA |
1:10,000 |
Immunohistochemistry | 1:50-1:100 |
Immunoprecipitation |
1:200 |
Western Blot |
1:500 |
|
|
Uniprot # |
|
Overview |
Component of a protein kinase signal transduction cascade. Activates the CSBP2, P38 and JNK MAPK pathways, but not the ERK pathway. Specifically phosphorylates and activates MAP2K4 and MAP2K6. |
Molecular Function |
Kinase, Serine/threonine-protein kinase, Transferase |
Subcellular Location |
Cytoplasm > perinuclear region |
Expression |
Expressed at high levels in heart, placenta, skeletal muscle and pancreas, and at lower levels in other tissues. |
Structure |
Belongs to the protein kinase superfamily. STE Ser/Thr protein kinase family. MAP kinase kinase kinase subfamily. Contains 1 protein kinase domain. |
Alternative Nomenclature |
dJ473J16.1 (mitogen-activated protein kinase kinase kinase 4) antibody FLJ42439 antibody KIAA0213 antibody MAP three kinase 1 antibody MAP/ERK kinase kinase 4 antibody MAP3K4 antibody MAPKKK4 antibody MEK kinase 4 antibody MEKK4 antibody Mitogen-activated protein kinase kinase kinase 4 antibody MTK1 antibody predicted protein of HQ0412 antibody PRO0412 antibody RP3-473J16.4 antibody SSK2/SSK22 MAP kinase kinase kinase, yeast, homolog of antibody |
Protein information supplied by UniProt
Product | Note | Status | Price | |
---|---|---|---|---|
|
MAP3K4-101AP | |||
|
MAP3K4-FITC | |||
|
PC-MAP3K4 | |||
|
P-MAP3K4 | |||
Display accessory details |
Select your currency:
(c) FabGennix International Inc.